JHVEPhoto
Medtronic (NYSE:MDT) said that it has received EU regulatory approval for its Inceptiv closed-loop spinal cord stimulator for the treatment of chronic pain.
The medical device maker said that device will be made available commercially in Europe in the coming months. The product is not approved for sale in the US.
More on Medtronic
- Medtronic Q1 2024 Earnings Review: Management Placates The Market
- Medtronic: The Tide Is Turning
- Medtronic plc (MDT) Q1 2024 Earnings Call Transcript
- Medtronic plc 2024 Q1 - Results - Earnings Call Presentation
- Medtronic slips as FDA panel votes against blood pressure treatment
- Medtronic raises guidance as Q1 results exceed forecasts
- Medtronic Non-GAAP EPS of $1.20 beats by $0.09, revenue of $7.7B beats by $140M
- Can Medtronic beat negative forecasts with Q1 results?
- Seeking Alpha’s Quant Rating on Medtronic
- Earnings data for Medtronic
- Dividend scorecard for Medtronic